|
TXNRD3IT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.8261999952004E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.379200E-04 |
| Normal-vs-Stage2 |
2.179600E-02 |
| Normal-vs-Stage3 |
1.617820E-01 |
| Normal-vs-Stage4 |
1.663790E-02 |
| Stage1-vs-Stage2 |
4.421600E-01 |
| Stage1-vs-Stage3 |
8.050800E-01 |
| Stage1-vs-Stage4 |
1.024470E-03 |
| Stage2-vs-Stage3 |
4.878800E-01 |
| Stage2-vs-Stage4 |
2.324800E-03 |
| Stage3-vs-Stage4 |
1.864070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59020000009858E-07 |
| Normal-vs-AfricanAmerican |
1.063190E-03 |
| Normal-vs-Asian |
7.131400E-01 |
| Caucasian-vs-AfricanAmerican |
8.176200E-01 |
| Caucasian-vs-Asian |
4.289600E-01 |
| AfricanAmerican-vs-Asian |
4.423200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.39119999995352E-06 |
| Normal-vs-Female |
2.7830000000062E-06 |
| Male-vs-Female |
5.362300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.724400E-02 |
| Normal-vs-Extreme_Weight |
1.059940E-02 |
| Normal-vs-Obese |
2.391000E-04 |
| Normal-vs-Extreme_Obese |
5.442800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.936000E-01 |
| Normal_Weight-vs-Obese |
9.019700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.726800E-01 |
| Extreme_Weight-vs-Obese |
1.864170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.048200E-01 |
| Obese-vs-Extreme_Obese |
3.848000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.568490E-02 |
| Normal-vs-Age(41-60Yrs) |
3.57680000000471E-05 |
| Normal-vs-Age(61-80Yrs) |
3.25820000002253E-06 |
| Normal-vs-Age(81-100Yrs) |
4.352200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.304400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.009800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.734600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.730200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.119600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.943400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.54076792727665E-12 |
| Normal-VS-Type2 PRCC |
7.611400E-01 |
| Normal-VS-KIRP CIMP |
3.185200E-01 |
| Normal-VS-Unclassified PRCC |
9.302800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.84030000028157E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.439830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.258400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.558200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.165500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.336800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.635200E-01 |
| Normal-vs-N1 |
2.974000E-01 |
| Normal-vs-N2 |
1.085250E-01 |
| N0-vs-N1 |
5.457800E-01 |
| N0-vs-N2 |
3.929200E-01 |
| N1-vs-N2 |
2.996600E-01 |
|
|
